| [1] |
Ren Sun¹, Wang Rong¹, Min Wei².
Stevens-Johnson syndrome and toxic epidermal necrolysis induced by programmed cell death 1 inhibitors: a clinical analysis of 13 cases
[J]. Chinese Journal of Dermatology, 2026, 59(9): 888-892.
|
| [2] |
Gao Haiqing, Ma Li, Yang Fanping, Chen Sheng'an, Zhao Ying, Luo Xiaoqun.
Clinical and genetic characteristics of 36 patients with hereditary angioedema
[J]. Chinese Journal of Dermatology, 2026, 59(9): 881-887.
|
| [3] |
Li Yanhong, Jiang Kun, Wu Zhuoxuan, Zhang Jianlan, Fang Meizhen, Liu Shuting, Wang Linlin, Hu Lei, Zhou Xiaoyong, Chen Liuqing, Chen Jinbo.
Analysis of 18 cases of cutaneous adverse reactions associated with programmed death-1 inhibitors
[J]. Chinese Journal of Dermatology, 2026, 59(8): 783-787.
|
| [4] |
Qin Wanyi, Lu Yonghong, Tang Xinyun, Zhou Sijie, Zhou Peimei.
One-year drug survival analysis of dupilumab and Janus kinase 1 inhibitors in the treatment of moderate-to-severe atopic dermatitis
[J]. Chinese Journal of Dermatology, 2026, 59(6): 512-518.
|
| [5] |
Li Wei¹, Yao Xu².
Research on atopic dermatitis in China: current status and future perspectives
[J]. Chinese Journal of Dermatology, 2026, 59(6): 505-511.
|
| [6] |
Zhang Xiaoxu, Luo Suju.
Efficacy and safety of upadacitinib in the treatment of six cases of palmoplantar pustulosis
[J]. Chinese Journal of Dermatology, 2026, 59(5): 459-463.
|
| [7] |
Zhao Yuanyuan, Le Wenjing, Li Sai, Su Xiaohong.
Evaluation of in vitro antibacterial activity of antimicrobial peptides LL37 against Neisseria gonorrhoeae
[J]. Chinese Journal of Dermatology, 2026, 59(4): 343-348.
|
| [8] |
Chinese Society of Dermatology, China Dermatologist Association.
Chinese expert consensus on the diagnosis and treatment of angioedema (2026 edition)
[J]. Chinese Journal of Dermatology, 2026, 0(1): 20250706-e20250706.
|
| [9] |
Zhu Tingting, Li Weiran, Pan Zhaobing, Liu Hao, Tang Xianfa, Zhu Caihong, Huang Hequn, Duan Dawei, Zhang Ruochen, Chen Xiaojian, Wang Yang, Xue Qian, Zhang Jurui, Yang Lijing, Zhang Xuejun, Huang He, Zhang Bo, .
Efficacy of baricitinib combined with ruxolitinib cream in the treatment of six patients with progressive nonsegmental vitiligo: a clinical observation
[J]. Chinese Journal of Dermatology, 2025, 58(9): 856-859.
|
| [10] |
Lyu Shuying, Wang Ying, Lin Wenjun, Yang Dingquan.
Efficacy of combination therapy with tofacitinib in the treatment of alopecia ophiasis: a retrospective analysis of 21 cases
[J]. Chinese Journal of Dermatology, 2025, 58(7): 630-635.
|
| [11] |
Wei Ran, Li Qinfeng.
Novel targeted drugs for the treatment of pediatric alopecia areata
[J]. Chinese Journal of Dermatology, 2025, 58(7): 650-653.
|
| [12] |
Li Xiangqian, Zhang Jianzhong, Zhou Cheng.
Advances in the clinical research on systemic small-molecule drugs and biologics for the treatment of alopecia areata
[J]. Chinese Journal of Dermatology, 2025, 58(7): 646-649.
|
| [13] |
Qiu Li, Xiao Ting .
Bruton′s tyrosine kinase inhibitors in the treatment of chronic spontaneous urticaria
[J]. Chinese Journal of Dermatology, 2025, 58(6): 563-567.
|
| [14] |
Committee on Psoriasis, Chinese Society of Dermatology.
Expert proposal on apremilast for the treatment of psoriasis (2025 edition)
[J]. Chinese Journal of Dermatology, 2025, 58(5): 416-424.
|
| [15] |
Bai Lu, Chu Yan, Liu Yuanyuan, Zhu Caiyong.
Treatment of chronic hand eczema
[J]. Chinese Journal of Dermatology, 2025, 58(5): 477-480.
|